Keebeck Wealth Management

Position in ADMA — Adma Biologics, Inc.

CIK 1803675 Chicago, IL

Position in ADMA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$319,485

-$270,086 QoQ

Shares Held

35,459

+9.7% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Keebeck Wealth Management holds $1,033,322 across 3 Biotechnology names. ADMA ranks #2 (30.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	25,176	$623,357
2	ADMA	Adma Biologics, Inc. This page	35,459	$319,485
3	RLMD	Relmada Therapeutics, Inc.	13,000	$90,480

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$319,485	35,459	+9.7%	Shares	Other	2026-05-14
2025-12-31	$589,571	32,323	+67.1%	Shares	Other	2026-02-17
2025-09-30	$283,553	19,342	-8.8%	Shares	Other	2025-11-14
2025-06-30	$386,397	21,219	—	Shares	Other	2025-08-14
No filing history on record for this holder in this stock.